The drug continues do dominate the market for prescription weight-loss drugs in the U.S.
Lilly raises outlook for third time this year as Zepbound sales soar.

Ethereum Price Faces 525K ETH Supply Risk as ETF Outflows Mount
Blockonomi · 37 minutes ago
18 Years of Satoshi’s Paradox: Can Bitcoin Survive What Comes Next?
BeInCrypto · 1 hour ago


